ArticleOncoTargets and therapy2023

Ability of Blood Cell Parameters to Predict Clinical Outcomes of Nivolumab Monotherapy in Advanced Esophageal Squamous Cell Carcinoma.

Yoichi Hamai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.